A merger arbitrage opportunity exists with Semler Scientific (SMLR), which is being acquired by Strive Asset Management (ASST) at a significant premium. Investors bullish on ASST can consider buying SMLR to acquire the acquirer's stock at a potential discount, as SMLR trades for less than the value of its Bitcoin holdings. This trade is a bet that the high valuation of ASST will hold steady through the merger's completion. For a more straightforward investment in the Bitcoin treasury space, consider MicroStrategy (MSTR). MSTR is highlighted as the highest-quality, "blue-chip" alternative for gaining leveraged exposure to Bitcoin.

Semler Scientific (SMLR)

• SMLR is being acquired by Strive Asset Management (ASST) in a deal that values SMLR at a significant premium, approximately $90.52 per share.
• Under the terms of the merger, each share of SMLR will be converted into 21 shares of ASST.
• The company is described as having a "troubled shareholder base" after pivoting from a successful medical device company to a Bitcoin treasury company.
• SMLR is considered very cheap based on its MNAV (Market Cap to Net Asset Value, a ratio comparing the company's market value to the value of the Bitcoin it holds). It trades at an MNAV of 0.85, which is considered "ridiculous" even after a recent 12-15% price increase.
• The company's original medical device, Quantaflow, was a successful product until changes in Medicare reimbursement schedules effectively "killed" the business, leading to the pivot to Bitcoin.
• A historical legal issue, a settlement with the Department of Justice over a False Claims Act violation for $29.75 million, has been a negative factor or "overhang" on the stock's price.

Takeaways

• Buying SMLR is presented as a way to acquire shares of ASST, potentially at a discount, through the merger. This is known as a merger arbitrage play.
• This strategy is only recommended for investors who are already bullish on ASST and were considering buying it anyway.
• The primary risk is that the value of ASST stock could fall before the merger is complete, which would erase the potential arbitrage profit.
• There is also a risk that the merger could fail to get shareholder approval, though the high premium offered makes this less likely.

Strive Asset Management (ASST)

• ASST is acquiring SMLR by issuing new shares. The company will need to "print" approximately $1.39 billion worth of new shares to complete the purchase.
• The company is associated with its founder, Vivek Ramaswamy, and the stock may be trading at a premium due to his involvement (the "Ramaswamy premium").
• ASST trades at a "rich" valuation with an MNAV of approximately 2.8. This means its market capitalization is 2.8 times the value of the Bitcoin it holds on its balance sheet.
• A key part of ASST's strategy is to acquire companies with "trapped capital" on their balance sheets, particularly within the biotech space. The acquisition of SMLR is the first major execution of this strategy.
• The merger is expected to slightly lower ASST's MNAV to a theoretical 2.62, which is considered a manageable dilution because of its high starting valuation.

Takeaways

• The core investment thesis for ASST (and by extension, the SMLR arbitrage play) is a bet that its high MNAV will not collapse after the merger.
• Investors are betting on the company's unique strategy of acquiring undervalued biotech companies and the continued positive sentiment associated with its high-profile founder.
• Risk Factor: The acquisition is very large for ASST ("a merger of equals"), which introduces significant execution risk. There's a chance the market could re-evaluate ASST downwards after it absorbs SMLR and its history.
• Risk Factor: ASST could inherit potential liabilities from SMLR's old medical device business. The speaker questions if ASST should spin off the Quantaflow business to isolate this risk.

Investment Theme: Bitcoin Treasury Companies

• This is the sector that includes SMLR, ASST, MicroStrategy (MSTR), and MetaPlanet. These companies hold Bitcoin (BTC) as a primary treasury reserve asset.
• A key valuation metric discussed is MNAV (Market Cap to Net Asset Value).
  • A high MNAV (like ASST's ~2.8x) indicates the market values the company far more than the Bitcoin it holds, pricing in factors like strategy, management, or future growth.
  • A low MNAV (like SMLR's 0.85x) indicates the market values the company at less than the Bitcoin it holds, suggesting deep pessimism or other perceived risks.

Takeaways

• Investing in these companies is a leveraged way to gain exposure to Bitcoin, but it comes with company-specific risks and opportunities.
• The discussion highlights a spectrum of risk within the sector, from more speculative plays like the SMLR/ASST merger to more established "blue-chip" options.

MicroStrategy (MSTR)

• Mentioned as the speaker's preferred investment within the Bitcoin treasury company space.
• Described as the "bluest of the blue chips" in this category, implying it is perceived as the safest or highest-quality company in the sector.

Takeaways

• For investors interested in the Bitcoin treasury strategy but wary of the complexities and risks of the SMLR/ASST merger, MSTR is presented as a more straightforward, established alternative.
• It represents a bet on the "best of the best" in the space, according to the speaker.